GROKHOOD scan of $BOTBAL (Botensilimab and Balstilimab), Pons token 0x1f50a7ebf711993448da34f291849bc2dd9fc82c on Robinhood Chain.
Verdict: HIGH RISK (dev sold after launch). Safety Score 37/100 at launch (danger; bands: safe 70+, caution 40-69, danger below 40), computed 2026-11-05T14:02:07Z; the score covers the first 60 s only.
Launched 2026-11-04T19:56:23Z by deployer 0xaa4b79b0259750cd311b1727158635533591c636; bonding curve 2% filled.
After launch: the deployer sold 100% of the tokens it bought for 0.6285 ETH at 2026-11-04T19:56:51Z.
Reason: Shared funder: 18 of 26 early buyers trace back to one funder (0xdd14...c19d).
Reason: Bundled supply: 23.9% of supply was bought in the first 60 s by 18 wallets sharing funders (0% within 3 s).
Reason: Supply bought by exempt wallets: 1 exempt wallet bought 22.4% of supply in the first 60 s (22.4% within 3 s).
Ring: part of ring_beb7e69b92b0b055 tied by shared wallets on chain.
Insiders still hold 0.1% of supply (deployer, exempt wallets, first-60 s buyers, ring wallets; they sold 50% of their buys).
Bot service: launched through launch-bot service svc_005fd45d8839470c (103 launches); neutral info.
Facts are wallet history on chain, not claims about people. Not financial advice.
Details: https://www.grokhood.tech/token/0x1f50a7ebf711993448da34f291849bc2dd9fc82c